Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Menopause. 2020 Jan;27(1):57–65. doi: 10.1097/GME.0000000000001418

Figure 4.

Figure 4.

Change in hot flash frequency stratified by APOE genotype. 4A, APOE3/3 participants on PS50 showed significant reduction in hot flash frequency. 4B, APOE3/4 participants on PS50 showed non-significant decline in hot flash frequency relative to the placebo group. PS50, PhytoSERM 50gm/day; PS100, PhytoSERM 100mg/day. * p<0.05.